Mady Malheiros Barbeitas
Biographic Data
| ID | 879449 |
|---|---|
| NAME | Mady Malheiros Barbeitas |
| GIVEN NAMES | Mady Malheiros |
| FAMILY NAME | Barbeitas |
| SIGNATURE | BARBEITAS M M |
| AFFILIATIONS | Fundação Oswaldo Cruz, Brazil; French National Centre for Scientific Research, France |
| ORCID | 0000-0001-7015-4863 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Market Devices and the Assetization of Neglected Diseases
This article examines the market devices designed to address the "market failure" surrounding neglected diseases, focusing on international drug-development activities for leishmaniasis. Using public-private partnerships and the US Food and Drug Administration's Priority Review Voucher as key examples, the article explores how these initiatives have transformed drug development for neglected diseases over time. By tracing the history of two drug …
Rumo à equidade em saúde
Towards equity in health
O artigo discute a meta do Ministério da Saúde de produzir localmente 70% dos insumos para o Sistema Único de Saúde (SUS). A iniciativa visa reduzir a dependência externa, uma vulnerabilidade exposta durante a pandemia de COVID-19. Os autores destacam desafios como: Altos preços de medicamentos devido a patentes; A necessidade de desenvolver produtos para doenças negligenciadas, que não atraem o setor privado; A falta de produção nacional de insu…
Testing Covid-19 in Brazil
Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Unified National Health System (SUS). This communication presents the ini…
Testing Covid-19 in Brazil
Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Unified National Health System (SUS). This communication presents the ini…
Testing Covid-19 in Brazil
Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Unified National Health System (SUS). This communication presents the ini…
Rumo à equidade em saúde
Towards equity in health
O artigo discute a meta do Ministério da Saúde de produzir localmente 70% dos insumos para o Sistema Único de Saúde (SUS). A iniciativa visa reduzir a dependência externa, uma vulnerabilidade exposta durante a pandemia de COVID-19. Os autores destacam desafios como: Altos preços de medicamentos devido a patentes; A necessidade de desenvolver produtos para doenças negligenciadas, que não atraem o setor privado; A falta de produção nacional de insu…
Market Devices and the Assetization of Neglected Diseases
This article examines the market devices designed to address the "market failure" surrounding neglected diseases, focusing on international drug-development activities for leishmaniasis. Using public-private partnerships and the US Food and Drug Administration's Priority Review Voucher as key examples, the article explores how these initiatives have transformed drug development for neglected diseases over time. By tracing the history of two drug …
Political science (4 works) · Public Health in Brazil (3 works) · Business (2 works) · Economic growth (2 works) · Economics (2 works) · Geography (2 works) · Medicine (2 works) · Biotechnology and Related Fields (1 works) · Computer Science (1 works) · Coronavirus disease 2019 (COVID-19) (1 works)